IMVT icon

Immunovant

186 hedge funds and large institutions have $2.04B invested in Immunovant in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 61 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

10% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 61

9% less capital invested

Capital invested by funds: $2.24B → $2.04B (-$204M)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
186
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.9M
Puts
$18.2M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$4.12M
52
$3.87M
53
$3.81M
54
$3.77M
55
$3.75M
56
$3.7M
57
$3.64M
58
$3.6M
59
$3.59M
60
$3.53M
61
$3.21M
62
$3.02M
63
$2.89M
64
$2.68M
65
$2.5M
66
$2.48M
67
$2.44M
68
$2.36M
69
$2.28M
70
$2.15M
71
$2.15M
72
$2.11M
73
$2.1M
74
$2M
75
$2M